{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:28:07Z","timestamp":1765546087831,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Services Research and Development Service of the Department of Veterans Affairs"},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","doi-asserted-by":"crossref","award":["AR062133"],"award-info":[{"award-number":["AR062133"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ahj.2016.03.029","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T12:37:24Z","timestamp":1467031044000},"page":"186-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System"],"prefix":"10.1016","volume":"179","author":[{"given":"Joshua","family":"Buck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kaboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian F.","family":"Gage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1910-346X","authenticated-orcid":false,"given":"Peter","family":"Cram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary S.","family":"Vaughan Sarrazin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ahj.2016.03.029_bb0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.amjmed.2009.11.015","article-title":"Are atrial fibrillation patients receiving warfarin in accordance with stroke risk?","volume":"123","author":"Zimetbaum","year":"2010","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.ahj.2016.03.029_bb0010","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ahj.2016.03.029_bb0015","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1185\/03007995.2014.922061","article-title":"Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured","volume":"30","author":"Liu","year":"2014","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"10.1016\/j.ahj.2016.03.029_bb0020","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1253\/circj.CJ-14-0344","article-title":"Inappropriate use of oral anticoagulants for patients with atrial fibrillation","volume":"78","author":"Akao","year":"2014","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.ahj.2016.03.029_bb0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/CIRCOUTCOMES.113.000127","article-title":"Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry","volume":"6","author":"Cullen","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"11","key":"10.1016\/j.ahj.2016.03.029_bb0030","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2016.03.029_bb0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.thromres.2005.08.007","article-title":"Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis","volume":"118","author":"Lip","year":"2006","journal-title":"Thromb Res"},{"issue":"22","key":"10.1016\/j.ahj.2016.03.029_bb0040","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"5_Supplement","key":"10.1016\/j.ahj.2016.03.029_bb0045","doi-asserted-by":"crossref","first-page":"579S","DOI":"10.1378\/chest.114.5_Supplement.579S","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"114","author":"Laupacis","year":"1998","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.ahj.2016.03.029_bb0050","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jama.279.16.1273","article-title":"Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study","volume":"279","author":"The SPAF III","year":"1998","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ahj.2016.03.029_bb0055","first-page":"e257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"issue":"6_suppl","key":"10.1016\/j.ahj.2016.03.029_bb0060","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Antithrombotic therapy in atrial fibrillation*: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Singer","year":"2008","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.ahj.2016.03.029_bb0065","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2016.03.029_bb0070","first-page":"74","article-title":"Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter","volume":"27","author":"Cairns","year":"2011","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2016.03.029_bb0075","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.hrthm.2012.04.031","article-title":"Pharmacotherapy in Medicare beneficiaries with atrial fibrillation","volume":"9","author":"Piccini","year":"2012","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ahj.2016.03.029_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.ahj.2016.03.029_bb0085","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 Focused update of the ESC guidelines for the management of atrial fibrillation","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2016.03.029_bb0090","first-page":"125","article-title":"Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate\/rhythm control","volume":"28","author":"Skanes","year":"2012","journal-title":"Can J Cardiol"},{"issue":"2_suppl","key":"10.1016\/j.ahj.2016.03.029_bb0095","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.ahj.2016.03.029_bb0100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.ahj.2016.03.029_bb0105","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Investigators. Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"The ACTIVE","year":"2009","journal-title":"N Engl J Med"},{"issue":"9526","key":"10.1016\/j.ahj.2016.03.029_bb0110","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"ACTIVE Writing Group of the ACTIVE Investigators","year":"2006","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ahj.2016.03.029_bb0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.revmed.2015.03.330","article-title":"Anticoagulation in the aged patient with atrial fibrillation: what are prescribing cardiologists, geriatricians and general practitioners? [in French]","volume":"36","author":"Fuchs","year":"2015","journal-title":"Rev Med Int"},{"issue":"9","key":"10.1016\/j.ahj.2016.03.029_bb0120","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","volume":"60","author":"Apostolakis","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2016.03.029_bb0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.ahj.2016.03.029_bb0130","doi-asserted-by":"crossref","first-page":"666","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00048","article-title":"Assessing quality using administrative data","volume":"127","author":"Iezzoni","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ahj.2016.03.029_bb0135","first-page":"184","article-title":"Choices in the use of ICD-9 codes to identify stroke risk factors can affect the apparent population-level risk factor prevalence and distribution of CHADS2 scores","volume":"2","author":"Rothendler","year":"2012","journal-title":"Am J Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.ahj.2016.03.029_bb0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/j.1875-9114.2012.01023.x","article-title":"The CHADS2 versus the new CHA2DS2-VASc scoring systems for guiding antithrombotic treatment of patients with atrial fibrillation: review of the literature and recommendations for use","volume":"32","author":"Odum","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.ahj.2016.03.029_bb0145","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11606-015-3201-1","article-title":"Clinical benefit of American College of Chest Physicians versus European Society of Cardiology guidelines for stroke prophylaxis in atrial fibrillation","volume":"30","author":"Andrade","year":"2015","journal-title":"J Gen Intern Med"},{"year":"2012","series-title":"Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study","author":"Friberg","key":"10.1016\/j.ahj.2016.03.029_bb0150"},{"issue":"12","key":"10.1016\/j.ahj.2016.03.029_bb0155","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjmed.2015.05.044","article-title":"National trends in ambulatory oral anticoagulant use","volume":"128","author":"Barnes","year":"2015","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ahj.2016.03.029_bb0160","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1378\/chest.10-2436","article-title":"Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project","volume":"140","author":"Gorin","year":"2011","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ahj.2016.03.029_bb0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/europace\/eun369","article-title":"The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management","volume":"11","author":"Nabauer","year":"2009","journal-title":"Europace"},{"issue":"24","key":"10.1016\/j.ahj.2016.03.029_bb0170","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1093\/eurheartj\/ehl015","article-title":"Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation","volume":"27","author":"Nieuwlaat","year":"2006","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ahj.2016.03.029_bb0175","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/clc.22133","article-title":"Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial tibrillation: a Danish survey","volume":"36","author":"Brandes","year":"2013","journal-title":"Clin Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316300990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316300990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:57:31Z","timestamp":1757570251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870316300990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":35,"alternative-id":["S0002870316300990"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2016.03.029","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2016.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}